Prof. Dr. med. Julia C. Stingl
Medical Director
(Department of Clinical Pharmacology and Pharmacoepidemiology)
Medical/Professional background
- since 2025
Medical Director of the Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital Heidelberg
- 2019 – 2024
University Professor and Director of the Institute of Clinical Pharmacology, RWTH Aachen University Hospital
- 2012 – 2019
Vice president and head of the division of research, of the Federal Institute for Drugs and Medical devices, Bonn, Germany
- 2006 – 2012
Professor of Clinical Pharmacology, Department of Natural Medicine and Clinical Pharmacology, University of Ulm, Germany
- 2004 – 2006
Scientific postdoctoral fellow, Department of Pharmacology, University of Cologne, Köln, Germany (Prof. E. Schömig)
- 1999 – 2003
Training in Clinical Pharmacology, Charité University Medicine, Berlin, Germany (Prof. I. Roots)
- 1997 – 1999
Residency in Psychiatry, Psychiatric University Hospital, Freie Universität Berlin, Berlin, Germany (Prof. H. Helmchen)
Scientific background
- since 2025
Professor of Clinical Pharmacology, University of Heidelberg
- 2019
Professor of Molecular Pharmacology, RWTH Aachen
- 2006
Professor of Clinical Pharmacology, University of Ulm
- 2004
Private Dozent (Habilitation), Charité University Medicine, Berlin, Germany
- 2003
Board Certification Clinical Pharmacology
- 1997
Doctor of Medicine, University of Frankfurt/Main Medical School, Frankfurt, Germany
- 1991 – 1997
Human Medicine, University of Frankfurt/Main Medical school
Commendations
- 2010
Recipient of the Leon I. Goldberg Young Investigator Award 2010 of the American Society for Clinical Pharmacology and Therapeutics (ASCPT)
- 2009
Visiting Professor at the Office of Clinical Pharmacology, FDA Center for Drug Evaluation and Research, Washington DC, US (Award for three months visit)
- 2009
Recipient of the Utrecht Award for Pharmaceutical Research 2009
- 2003
American Society for Clinical Pharmacology and Therapeuics Washington "Presidential Trainee Award”
Offices and posts held
- since 2023
Appointed by the BMBF to represent Germany in the Working Group Pharmacogenetics of the 1+Million Genomes Project of the European Commission
- since 2021
Elected member of the Executive Committee of the European Association of Clinical Pharmacology, Treasurer of the EACPT (EACPT)
- 2019 – 2022
Appointed member of the Genetic Diagnostics Commission (GEKO)
- since 2019
Member of the working group “Wissen generieren durch Vernetzung von Forschung und Versorgung” (Generating knowledge by connecting research and care), Nationale Dekade gegen Krebs, BMBF
- since 2004
Associate Member of the Drug Commission of the German Medical Association, Berlin
Major Working Areas
Pharmacogenetics and Pharmacogenomics
Personalized Drug Therapy / Precision Dosing
Polypharmacy
Drug Interactions
Pharmacology of Ageing